Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
26,55 USD | +1,45% | +2,19% | -15,79% |
Attività
Numero di dipendenti: 180
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Nucleic Acid-focused Technology
100,0
%
| 206 | 100,0 % | 167 | 100,0 % | -19,03% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 206 | 100,0 % | 167 | 100,0 % | -19,03% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joseph Payne
CEO | Chief Executive Officer | 52 | 01/03/13 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01/09/19 |
Chief Operating Officer | 45 | 01/01/13 | |
Chief Tech/Sci/R&D Officer | 68 | 01/03/23 | |
Neda Safarzadeh
IRC | Investor Relations Contact | - | - |
Lance Kurata
LAW | General Counsel | 54 | 10/08/20 |
Kevin T. Skol
PRN | Corporate Officer/Principal | - | 01/01/02 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Edward W. Holmes
BRD | Director/Board Member | 83 | 01/09/19 |
James F. Barlow
BRD | Director/Board Member | 65 | 27/05/18 |
Peter Farrell
CHM | Chairman | 81 | 27/05/18 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01/09/19 |
Magda Marquet
BRD | Director/Board Member | 65 | 27/05/18 |
Jing Marantz
BRD | Director/Board Member | 59 | 07/12/21 |
Joseph Payne
CEO | Chief Executive Officer | 52 | 01/03/13 |
John Markels
BRD | Director/Board Member | 58 | 08/12/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 26 915 243 | 24 560 665 ( 91,25 %) | 0 | 91,25 % |
Coordinate società
Arcturus Therapeutics Holdings, Inc.
10628 Science Center Drive Suite 250
92121, San Diego
+
http://www.arcturusrx.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-15,79% | 715 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione ARCT
- Società Arcturus Therapeutics Holdings Inc.